Skip to main content
. 2021 May 12;9(5):492. doi: 10.3390/vaccines9050492

Table 4.

Comparison of FAMA and gpEIA titers in subjects who had not seroconverted after vaccination.

Subject No. FAMA gpEIA (mIU/mL)
Pre-Vaccination Post-Vaccination Pre-Vaccination Post-Vaccination
28 <2 4 6.42 16.96
34 <2 2 8.70 10.65
37 4 8 53.43 59.53
42 2 8 9.53 29.62